CoreWeave Faces a Wave of Doubt. Rival Nebius Is Helping Lift the Mood. - Barron's
1. CoreWeave's stock has declined about 33% since June's peak. 2. Analysts question CoreWeave's valuation due to debt and reliance on Microsoft. 3. CoreWeave's acquisition of Core Scientific depends on share performance. 4. Nebius Group's strong earnings report boosts CoreWeave's stock temporarily. 5. Investor sentiment wavers, particularly with upcoming IPO lockup expiration.